Recovery ⏱ Half-life: Short. Preclinical

Cartalax

Cartalax (AKG Peptide)

Updated March 15, 2026

Evidence at a Glance

Regulatory statusPreclinical
Khavinson cartilage bioregulator (short peptide, sequence reported inconsistently); Russian-origin data only, not FDA-approved.
Human evidenceNone
Animal evidenceLimited

Cartalax is a Khavinson short-peptide bioregulator studied for cartilage/chondrocyte activity in animal models, with no controlled human clinical trials.

What the research does not support

  • It is not FDA-approved and is not a proven treatment for osteoarthritis or joint damage.
  • No human trials demonstrate cartilage regeneration; supporting data come from rodent histology studies only.
  • Its exact amino-acid sequence is reported inconsistently across vendor and reference sources, reflecting weak, non-independent documentation.
Half-Life
Short.
Mol. Weight
~317 g/mol

What is Cartalax?

Cartalax is a synthetic peptide bioregulator designed to support cartilage tissue maintenance and joint health.

Research Applications

Cartilage repair, osteoarthritis research, chondrocyte function, and joint tissue degeneration models.

Dosage Information (Research Use)

10-20 mg/day for 10-30 day courses. Research use only.

Reconstitution & Handling

Standard.

Half-Life & Pharmacokinetics

Short.

Reported Observations in Literature

Generally well-tolerated.

Key Research References

  • Khavinson VK. “Peptide Bioregulators.” 2003

How Cartalax Works

Cartalax modulates chondrocyte gene expression and supports extracellular matrix synthesis in cartilage tissue.

Research Findings

Studied in osteoarthritis models for cartilage preservation and joint tissue support.

Dosage & Administration

10-20 mg/day for 10-30 day courses. Research use only.

Safety & Side Effects

Generally well-tolerated.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Sequence Ala-Glu-Asp
Molecular Weight ~317 g/mol
Half-Life Short.
Available Sizes 5mg
Storage Lyophilized: -20°C.

Key Research References

  • Khavinson VK. "Peptide Bioregulators." 2003

Related Peptides

View all →
Thymosin Beta-4
Recovery
The complete 43-amino acid protein behind TB-500's regenerative properties — orchestrates tissue repair, cell migration, and wound healing.
View Profile → Buy Now
Vosoritide
Recovery
FDA-approved modified C-type natriuretic peptide analog that promotes bone growth in children with achondroplasia.
View Profile →
Linaclotide
Recovery
FDA-approved 14-amino acid peptide for IBS-C and chronic constipation that works by activating guanylate cyclase-C receptors in the…
View Profile →